SCYNEXIS Inc (SCYX) stock
SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3071% below fair value
$2.91−0.30 (-9.35%)
Close on Nov 16, 2026Market cap $28.95MP/E –Yield –
Scynexis operating margin
Operating margin is operating income as a percentage of revenue.
Scynexis's operating margin for the twelve months ending Jun 30, 2026 was -117.6%. For fiscal 2025 it was -78.0%, against -990.8% the year before. The highest annual figure on record is 51.9% in fiscal 2023.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -78.0% | +912.8 |
| FY2024 | Dec 31, 2024 | -990.8% | −1042.7 |
| FY2023 | Dec 31, 2023 | 51.9% | +1736.3 |
| FY2022 | Dec 31, 2022 | -1684.5% | −1222.3 |
| FY2021 | Dec 31, 2021 | -462.2% | +39968.4 |
| FY2019 | Dec 31, 2019 | -40430.6% | −28764.0 |
| FY2018 | Dec 31, 2018 | -11666.5% | −1425.3 |
| FY2017 | Dec 31, 2017 | -10241.2% | +582.5 |
| FY2016 | Dec 31, 2016 | -10823.7% | +207.0 |
| FY2015 | Dec 31, 2015 | -11030.7% | −9864.6 |
| FY2014 | Dec 31, 2014 | -1166.2% | −1123.4 |
| FY2013 | Dec 31, 2013 | -42.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -3308.5% | +41.7 |
| Q4 FY2025 | Dec 31, 2025 | 56.4% | +880.7 |
| Q3 FY2025 | Sep 30, 2025 | -2516.5% | −952.8 |
| Q2 FY2025 | Jun 30, 2025 | -701.0% | +554.1 |
| Q1 FY2025 | Mar 31, 2025 | -3350.2% | −2657.7 |
| Q4 FY2024 | Dec 31, 2024 | -824.3% | −426.4 |
| Q3 FY2024 | Sep 30, 2024 | -1563.6% | −990.2 |
| Q2 FY2024 | Jun 30, 2024 | -1255.0% | −1343.7 |
| Q1 FY2024 | Mar 31, 2024 | -692.5% | +252.8 |
| Q4 FY2023 | Dec 31, 2023 | -397.9% | +1077.3 |
| Q3 FY2023 | Sep 30, 2023 | -573.4% | +826.8 |
| Q2 FY2023 | Jun 30, 2023 | 88.6% | +1731.7 |
| Q1 FY2023 | Mar 31, 2023 | -945.3% | +1927.8 |
| Q4 FY2022 | Dec 31, 2022 | -1475.1% | +2259.7 |
| Q3 FY2022 | Sep 30, 2022 | -1400.2% | +2367.4 |
| Q2 FY2022 | Jun 30, 2022 | -1643.1% | −1629.9 |
| Q1 FY2022 | Mar 31, 2022 | -2873.1% | +16769.0 |
| Q4 FY2021 | Dec 31, 2021 | -3734.8% | +14798.0 |
| Q3 FY2021 | Sep 30, 2021 | -3767.6% | +9966.7 |
| Q1 FY2021 | Mar 31, 2021 | -13.2% | +9833.6 |
| Q2 FY2019 | Jun 30, 2019 | -19642.1% | −7676.5 |
| Q1 FY2019 | Mar 31, 2019 | -18532.8% | −7231.3 |
| Q4 FY2018 | Dec 31, 2018 | -13734.4% | −2545.3 |
| Q3 FY2018 | Sep 30, 2018 | -9846.9% | +151.6 |
| Q2 FY2018 | Jun 30, 2018 | -11965.6% | −1426.6 |
| Q1 FY2018 | Mar 31, 2018 | -11301.6% | −1901.6 |
| Q4 FY2017 | Dec 31, 2017 | -11189.1% | −2526.0 |
| Q3 FY2017 | Sep 30, 2017 | -9998.4% | +479.7 |
| Q2 FY2017 | Jun 30, 2017 | -10539.1% | – |
| Q1 FY2017 | Mar 31, 2017 | -9400.0% | – |
| Q4 FY2016 | Dec 31, 2016 | -8663.1% | – |
| Q3 FY2016 | Sep 30, 2016 | -10478.1% | – |
See a number that looks wrong?